Biree Andemariam, MD
Hematology & Oncology · Farmington, CTNPI 1396935136
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $566,674 of the $645,715 with a category attached, or 87.8%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.4%. 2025 is the largest year on record at $147,341, 3.8 times the $38,702 reported in 2019. Among hematology & oncology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $2043.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$151K
- Agios Pharmaceuticals, Inc.$108K
- Vertex$77K
- Pfizer$76K
- Novo Nordisk Health Care AG$52K
- Genetix Biotherapeutics Inc$32K
- plus $150K from 19 others
Across 157 payments — averaging $6409.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Global Blood Therapeutics, Inc.$724K
- Novartis$132K
- Agios Pharmaceuticals, Inc.$111K
- Novo Nordisk AS$29K
- Pfizer$11K
- Novo Nordisk$125
What the payments were for
- Consulting fees$566,67488%
- Speaking & faculty fees$51,8358%
- Travel & lodging$22,3583%
- Food & beverage$4,8351%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 42 | $150,998 |
| Agios Pharmaceuticals, Inc. | 73 | $108,007 |
| Vertex | 36 | $76,793 |
| Pfizer | 39 | $76,085 |
| Novo Nordisk Health Care AG | 18 | $51,598 |
| Genetix Biotherapeutics Inc | 5 | $32,300 |
| Novo Nordisk | 13 | $26,700 |
| Sanofi | 11 | $25,847 |
| Novartis | 19 | $25,118 |
| Bioverativ Therapeutics Inc. | 11 | $12,240 |
| E.r. Squibb & Sons, L.L.C. | 6 | $10,682 |
| Novo Nordisk AS | 6 | $9,450 |
| Genentech USA, Inc. | 6 | $8,121 |
| Merck | 9 | $7,111 |
| Sanofi US Services Inc. | 1 | $4,986 |
| Octapharma USA, Inc. | 1 | $4,000 |
| Omeros Corporation | 1 | $2,800 |
| F. Hoffmann-la Roche AG | 2 | $2,696 |
| HEMA Biologics, LLC | 1 | $2,500 |
| Terumo BCT, Inc. | 4 | $2,375 |
| GSK | 1 | $2,000 |
| Bayer | 2 | $1,120 |
| Tersera Therapeutics LLC | 1 | $1,110 |
| Emmaus Medical, Inc. | 7 | $1,065 |
| Seagen Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXBRYTA$158,168
- PYRUKYND$105,879
- SKYSONA$32,300
- Zynteglo$32,300
- ADAKVEO$15,293
- HYMPAVZI$9,680
- NO PRODUCT DISCUSSED$8,308
- HEMLIBRA$8,091
- LYFGENIA$3,740
- TALZENNA$3,716
- narsoplimab$2,800
- SevenFact$2,500
- Spectra Optia Apheresis System$2,375
- KEYTRUDA$1,311
- QUZYTTIR$1,110
- Jivi$1,088
- Non-Covered Product$1,056
- Endari$833
- ELOCTATE$118
- ALPROLIX$110
How this compares
$645,715 in reported general payments places this provider in the 95th percentile of 163 hematology & oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Farmington
- Aakash DesaiFarmington$54K
- Oladipo ColeFarmington$44K
- Jeffrey WasserFarmington$22K
- Swarup KumarFarmington$12K
- Robert BonaFarmington$7K
- Amer ZeidanNew Haven$807K
- Paul WeinsteinStamford$288K
- Walid ShaibNew Haven$217K
- Madhavi GorusuHartford$207K
- Dinesh KapurNorwich$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.